Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemiaAnjali S. Advani, Wendy Stock, Eric Larsen et al.|Blood Advances|2021Cited by 53
Frontline-Treatment Of Acute Lymphoblastic Leukemia (ALL) In Older Adolescents and Young Adults (AYA) Using a Pediatric Regimen Is Feasible: Toxicity Results of the Prospective US Intergroup Trial C10403 (Alliance)Anjali S. Advani, Wendy Stock, Ben L. Sanford et al.|Blood|2013Cited by 47
Sirolimus Plus MEC Chemotherapy Has Significant Activity in High Risk AML Patients Especially Those Who Exhibit in Vivo Inhibition of the mTOR PathwayMargaret Kasner, Alexander E. Perl, John L. Wagner et al.|Blood|2012Cited by 3